Progyny Operating Margin from 2010 to 2025
| PGNY Stock | USD 21.49 0.56 2.54% |
Check Progyny financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Progyny's main balance sheet or income statement drivers, such as Tax Provision of 30.3 M, Net Interest Income of 16.5 M or Interest Income of 19 M, as well as many indicators such as Price To Sales Ratio of 1.28, Dividend Yield of 0.0 or PTB Ratio of 3.55. Progyny financial statements analysis is a perfect complement when working with Progyny Valuation or Volatility modules.
Progyny | Operating Margin |
Latest Progyny's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Progyny over the last few years. It is Progyny's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Progyny's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.05 % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Progyny Operating Margin Regression Statistics
| Arithmetic Mean | (0.09) | |
| Coefficient Of Variation | (162.06) | |
| Mean Deviation | 0.14 | |
| Median | (0.03) | |
| Standard Deviation | 0.14 | |
| Sample Variance | 0.02 | |
| Range | 0.3478 | |
| R-Value | 0.87 | |
| Mean Square Error | 0.01 | |
| R-Squared | 0.75 | |
| Significance | 0.000013 | |
| Slope | 0.03 | |
| Total Sum of Squares | 0.31 |
Progyny Operating Margin History
About Progyny Financial Statements
Progyny investors use historical fundamental indicators, such as Progyny's Operating Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Progyny. Please read more on our technical analysis and fundamental analysis pages.
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. Progyny operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 311 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Progyny Stock Analysis
When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.